Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction

Maria Mahmood; Professor Gregory Lip

doi:10.1016/j.rec.2018.05.015

Related publications

Article2018

Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction

Tatjana Potpara, Charles J. Ferro, Professor Gregory Lip

Article2019

Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation

Tze‐Fan Chao, Chern-En Chiang, Jo‐Nan Liao, Tzeng‐Ji Chen, Professor Gregory Lip, Shih‐Ann Chen

Article2020

Inappropriate dose of nonvitamin-K antagonist oral anticoagulants: prevalence and impact on clinical outcome in patients with nonvalvular atrial fibrillation

Cosmo Godino, Francesca Bodega, Francesco Melillo, Francesca Rubino, Antonio Luca Maria Parlati, Alberto Cappelletti, Patrizio Mazzone, Paolo Mattiello, Paolo Della Bella, Alessandro Castiglioni, Ottavio Alfieri, Michele De Bonis, Matteo Montorfano, Moreno Tresoldi, Massimo Filippi, Alberto Zangrillo, Anna Salerno, Michela Cera, Alberto Margonato

Article2018

Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated “Real-World” in Patients With Atrial Fibrillation

María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Vanessa Roldán, Esteban Orenes‐Piñero, Giulio Francesco Romiti, Imma Romanazzi, Ying Bai, João Carmo, Marco Proietti, Francisco Marı́n, Professor Gregory Lip

Article2019

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study

Mette Søgaard, Flemming Skjøth, Martin Jensen, Jette Nordstrøm Kjældgaard, Professor Gregory Lip, Torben Bjerregaard Larsen, Peter Brønnum Nielsen